Synergy CHC Corp. Selling and Marketing Expense
Synergy CHC Corp. (SNYR) reported Selling and Marketing Expense of $2.46 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-05-14
- Synergy CHC Corp. selling and marketing expense for the quarter ending 2026-03-31 was $2.46M, a 14.62% decline year-over-year.
- Synergy CHC Corp. selling and marketing expense for the quarter ending 2025-12-31 was $4.47M, a 16.33% increase year-over-year.
- Synergy CHC Corp. selling and marketing expense for the quarter ending 2025-09-30 was $2.73M, a 8.78% increase year-over-year.
- Synergy CHC Corp. selling and marketing expense for the quarter ending 2025-06-30 was $3.06M, a 0.23% increase year-over-year.
- Synergy CHC Corp. selling and marketing expense for fiscal 2025 was $13.14M, a 1.13% increase from fiscal 2024.
- Synergy CHC Corp. selling and marketing expense for fiscal 2024 was $12.99M, a 14.47% decline from fiscal 2023.
- Synergy CHC Corp. selling and marketing expense for fiscal 2023 was $15.19M.
- Synergy CHC Corp. selling and marketing expense for fiscal 2019 was $11.47M, a 35.18% decline from fiscal 2018.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 12 month | Selling and Marketing Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | $2.46M 10-Q · filed 2026-05-14 | $6.93M derived: sum of 2 quarters · filed 2026-05-14 | $9.66M derived: sum of 3 quarters · filed 2026-05-14 | $12.72M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2025-12-31 | $4.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $7.20M derived: sum of 2 quarters · filed 2026-04-01 | $10.26M derived: sum of 3 quarters · filed 2026-04-01 | $13.14M 10-K · filed 2026-04-01 | |
| 2025-09-30 | $2.73M 10-Q · filed 2025-11-13 | $5.79M derived: sum of 2 quarters · filed 2025-11-13 | $8.67M 10-Q · filed 2025-11-13 | $12.51M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2025-06-30 | $3.06M 10-Q · filed 2025-08-14 | $5.94M 10-Q · filed 2025-08-14 | $9.78M derived: sum of 3 quarters · filed 2026-05-14 | $12.29M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2025-03-31 | $2.88M 10-Q · filed 2026-05-14 | $6.72M derived: sum of 2 quarters · filed 2026-05-14 | $9.23M derived: sum of 3 quarters · filed 2026-05-14 | $12.28M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $3.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $6.35M derived: sum of 2 quarters · filed 2026-04-01 | $9.41M derived: sum of 3 quarters · filed 2026-04-01 | $12.99M 10-K · filed 2026-04-01 | |
| 2024-09-30 | $2.51M 10-Q · filed 2025-11-13 | $5.56M derived: sum of 2 quarters · filed 2025-11-13 | $9.15M 10-Q · filed 2025-11-13 | $13.80M derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | $3.06M 10-Q · filed 2025-08-14 | $6.64M 10-Q · filed 2025-08-14 | $11.30M derived: sum of 3 quarters · filed 2025-08-14 | $15.60M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $3.58M 10-Q · filed 2025-05-15 | $8.24M derived: sum of 2 quarters · filed 2025-05-15 | $12.54M derived: sum of 3 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $4.66M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $8.96M derived: sum of 2 quarters · filed 2025-03-31 | $15.19M 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $4.30M 10-Q · filed 2024-12-06 | $10.53M 10-Q · filed 2024-12-06 | |||
| 2020-03-31 | $2.25M 10-Q · filed 2020-06-29 | $4.99M derived: sum of 2 quarters · filed 2020-06-29 | $7.77M derived: sum of 3 quarters · filed 2020-06-29 | $10.41M derived: sum of 4 quarters · filed 2020-06-29 | |
| 2019-12-31 | $2.74M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-29 | $5.51M derived: sum of 2 quarters · filed 2020-04-29 | $8.16M derived: sum of 3 quarters · filed 2020-04-29 | $11.47M 10-K · filed 2020-04-29 | |
| 2019-09-30 | $2.77M 10-Q · filed 2019-11-14 | $5.42M derived: sum of 2 quarters · filed 2019-11-14 | $8.73M 10-Q · filed 2019-11-14 | $13.07M derived: sum of 4 quarters · filed 2020-06-29 | |
| 2019-06-30 | $2.65M 10-Q · filed 2019-08-13 | $5.96M 10-Q · filed 2019-08-13 | $10.30M derived: sum of 3 quarters · filed 2020-06-29 | $14.26M derived: sum of 4 quarters · filed 2020-06-29 | |
| 2019-03-31 | $3.31M 10-Q · filed 2020-06-29 | $7.65M derived: sum of 2 quarters · filed 2020-06-29 | $11.61M derived: sum of 3 quarters · filed 2020-06-29 | $16.76M derived: sum of 4 quarters · filed 2020-06-29 | |
| 2018-12-31 | $4.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-29 | $8.30M derived: sum of 2 quarters · filed 2020-04-29 | $13.45M derived: sum of 3 quarters · filed 2020-04-29 | $17.70M 10-K · filed 2020-04-29 | $16.33M 10-K · filed 2019-03-29 |
| 2018-09-30 | $3.96M 10-Q · filed 2019-11-14 | $9.11M derived: sum of 2 quarters · filed 2019-11-14 | $13.36M 10-Q · filed 2019-11-14 | $16.60M derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | $5.15M 10-Q · filed 2019-08-13 | $9.40M 10-Q · filed 2019-08-13 | $12.64M derived: sum of 3 quarters · filed 2019-08-13 | $16.32M derived: sum of 4 quarters · filed 2019-08-13 | |
| 2018-03-31 | $4.25M 10-Q · filed 2019-05-03 | $7.49M derived: sum of 2 quarters · filed 2019-05-03 | $11.18M derived: sum of 3 quarters · filed 2019-05-03 | $15.40M derived: sum of 4 quarters · filed 2019-05-03 | |
| 2017-12-31 | $3.24M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $6.92M derived: sum of 2 quarters · filed 2019-03-29 | $11.15M derived: sum of 3 quarters · filed 2019-03-29 | $14.04M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $3.69M 10-Q · filed 2018-11-13 | $7.91M derived: sum of 2 quarters · filed 2018-11-13 | $10.81M 10-Q · filed 2018-11-13 | $14.45M derived: sum of 4 quarters · filed 2018-11-13 | |
| 2017-06-30 | $4.22M 10-Q · filed 2018-08-14 | $7.12M 10-Q · filed 2018-08-14 | $10.77M derived: sum of 3 quarters · filed 2018-08-14 | $13.82M derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | $2.90M 10-Q · filed 2018-05-15 | $6.54M derived: sum of 2 quarters · filed 2018-05-15 | $9.59M derived: sum of 3 quarters · filed 2018-05-15 | $11.78M derived: sum of 4 quarters · filed 2018-05-15 | |
| 2016-12-31 | $3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $6.70M derived: sum of 2 quarters · filed 2018-04-02 | $8.89M derived: sum of 3 quarters · filed 2018-04-02 | $10.33M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $3.05M 10-Q · filed 2017-11-13 | $5.24M derived: sum of 2 quarters · filed 2017-11-13 | $6.69M 10-Q · filed 2017-11-13 | $8.15M derived: sum of 4 quarters · filed 2017-11-13 | |
| 2016-06-30 | $2.19M 10-Q · filed 2017-08-14 | $3.64M 10-Q · filed 2017-08-14 | $5.09M derived: sum of 3 quarters · filed 2017-08-14 | $5.91M derived: sum of 4 quarters · filed 2017-08-14 | |
| 2016-03-31 | $1.45M 10-Q · filed 2017-05-01 | $2.90M derived: sum of 2 quarters · filed 2017-05-01 | $3.72M derived: sum of 3 quarters · filed 2017-05-01 | $4.40M derived: sum of 4 quarters · filed 2017-05-01 | |
| 2015-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | $2.27M derived: sum of 2 quarters · filed 2017-03-24 | $2.95M derived: sum of 3 quarters · filed 2017-03-24 | $3.69M 10-K · filed 2017-03-24 | |
| 2015-09-30 | $814.64K 10-Q · filed 2016-10-26 | $1.49M derived: sum of 2 quarters · filed 2016-10-26 | $2.23M 10-Q · filed 2016-10-26 | ||
| 2015-06-30 | $680.19K 10-Q · filed 2016-08-05 | $1.41M 10-Q · filed 2016-08-05 | |||
| 2015-03-31 | $733.59K 10-Q · filed 2016-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |